Suppr超能文献

2型糖尿病与肠道微生物群:已知与未知的交叉点

Type 2 diabetes and gut microbiome: at the intersection of known and unknown.

作者信息

Upadhyaya Smitha, Banerjee Gautam

机构信息

a Unilever Research and Development ; Bangalore , India.

出版信息

Gut Microbes. 2015;6(2):85-92. doi: 10.1080/19490976.2015.1024918.

Abstract

The prevalence of metabolic syndrome is increasing rapidly across the globe. Though the prevalence of the disease is similar in population of upper middle income and high income countries, the age of affected population is lower in upper middle income countries. This is attributed to genetic as well as changing life style factors. The contributing factors for type 2 diabetes range from genetic/epigenetic disposal, intra uterine nutrition, dietary pattern to sedentary lifestyle. The role of the gut microbiota in metabolic disorders is increasingly gaining importance. Several studies have reported significant difference in the profile of the gut microbiota in Caucasian population considering obese and type 2 diabetic populations while limited number of studies are available on populations from the developing world. The metabolites from the gut microbes contribute to the gut barrier integrity and a compromised barrier leads to leakage of inflammatory mediators into systemic circulation and hence increases insulin resistance. Attempts have been made at correcting metabolic syndrome through dietary changes by altering the gut microbiota with some success. This report is an attempt to explain the hypothesis of compromised nutrition altering the gut microbiota, gut metabolites, gut barrier function, systemic inflammation and hence insulin response.

摘要

代谢综合征在全球范围内的患病率正在迅速上升。尽管该疾病在中高收入国家和高收入国家人群中的患病率相似,但中高收入国家受影响人群的年龄更低。这归因于遗传因素以及不断变化的生活方式因素。2型糖尿病的促成因素包括遗传/表观遗传倾向、子宫内营养、饮食模式以及久坐不动的生活方式。肠道微生物群在代谢紊乱中的作用日益重要。几项研究报告称,考虑到肥胖人群和2型糖尿病患者,白种人群肠道微生物群的特征存在显著差异,而针对发展中世界人群的研究数量有限。肠道微生物产生的代谢产物有助于维持肠道屏障的完整性,而受损的屏障会导致炎症介质泄漏到体循环中,从而增加胰岛素抵抗。人们已经尝试通过饮食改变来纠正代谢综合征,通过改变肠道微生物群取得了一些成功。本报告旨在解释营养受损改变肠道微生物群、肠道代谢产物、肠道屏障功能、全身炎症以及胰岛素反应这一假说。

相似文献

5
Role of the Gut Microbiome in Obesity and Diabetes Mellitus.肠道微生物群在肥胖和糖尿病中的作用。
Nutr Clin Pract. 2015 Dec;30(6):787-97. doi: 10.1177/0884533615609896. Epub 2015 Oct 9.
6
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.肠-肝轴、营养与非酒精性脂肪性肝病。
Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4.

引用本文的文献

4
Metagenomic functional profiling: to sketch or not to sketch?宏基因组功能谱分析:描绘还是不描绘?
Bioinformatics. 2024 Sep 1;40(Suppl 2):ii165-ii173. doi: 10.1093/bioinformatics/btae397.
6
Gut microbiota interacts with inflammatory responses in acute pancreatitis.肠道微生物群与急性胰腺炎中的炎症反应相互作用。
Therap Adv Gastroenterol. 2023 Oct 10;16:17562848231202133. doi: 10.1177/17562848231202133. eCollection 2023.
8
Gut microbiota, an emergent target to shape the efficiency of cancer therapy.肠道微生物群,塑造癌症治疗疗效的一个新靶点。
Explor Target Antitumor Ther. 2023;4(2):240-265. doi: 10.37349/etat.2023.00132. Epub 2023 Apr 26.

本文引用的文献

5
Microbiology: Wealth management in the gut.微生物学:肠道中的财富管理。
Nature. 2013 Aug 29;500(7464):538-9. doi: 10.1038/500538a.
9
Gut bacterial microbiota and obesity.肠道细菌微生物群与肥胖。
Clin Microbiol Infect. 2013 Apr;19(4):305-13. doi: 10.1111/1469-0691.12172. Epub 2013 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验